These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 28191936)
1. Development of Fluorophore-Labeled Thailanstatin Antibody-Drug Conjugates for Cellular Trafficking Studies. Kulkarni C; Finley JE; Bessire AJ; Zhong X; Musto S; Graziani EI Bioconjug Chem; 2017 Apr; 28(4):1041-1047. PubMed ID: 28191936 [TBL] [Abstract][Full Text] [Related]
2. An optimal "Click" formulation strategy for antibody-drug conjugate synthesis. Vatansever EC; Kang J; Tuley A; Ward ES; Liu WR Bioorg Med Chem; 2020 Dec; 28(24):115808. PubMed ID: 33071032 [TBL] [Abstract][Full Text] [Related]
3. Natural Product Splicing Inhibitors: A New Class of Antibody-Drug Conjugate (ADC) Payloads. Puthenveetil S; Loganzo F; He H; Dirico K; Green M; Teske J; Musto S; Clark T; Rago B; Koehn F; Veneziale R; Falahaptisheh H; Han X; Barletta F; Lucas J; Subramanyam C; O'Donnell CJ; Tumey LN; Sapra P; Gerber HP; Ma D; Graziani EI Bioconjug Chem; 2016 Aug; 27(8):1880-8. PubMed ID: 27412791 [TBL] [Abstract][Full Text] [Related]
4. Multivalent peptidic linker enables identification of preferred sites of conjugation for a potent thialanstatin antibody drug conjugate. Puthenveetil S; He H; Loganzo F; Musto S; Teske J; Green M; Tan X; Hosselet C; Lucas J; Tumey LN; Sapra P; Subramanyam C; O'Donnell CJ; Graziani EI PLoS One; 2017; 12(5):e0178452. PubMed ID: 28558059 [TBL] [Abstract][Full Text] [Related]
5. Genetically Encoded Azide Containing Amino Acid in Mammalian Cells Enables Site-Specific Antibody-Drug Conjugates Using Click Cycloaddition Chemistry. VanBrunt MP; Shanebeck K; Caldwell Z; Johnson J; Thompson P; Martin T; Dong H; Li G; Xu H; D'Hooge F; Masterson L; Bariola P; Tiberghien A; Ezeadi E; Williams DG; Hartley JA; Howard PW; Grabstein KH; Bowen MA; Marelli M Bioconjug Chem; 2015 Nov; 26(11):2249-60. PubMed ID: 26332743 [TBL] [Abstract][Full Text] [Related]
6. Development and Evaluation of a Fluorescent Antibody-Drug Conjugate for Molecular Imaging and Targeted Therapy of Pancreatic Cancer. Knutson S; Raja E; Bomgarden R; Nlend M; Chen A; Kalyanasundaram R; Desai S PLoS One; 2016; 11(6):e0157762. PubMed ID: 27336622 [TBL] [Abstract][Full Text] [Related]
7. Selecting an optimal antibody for antibody-drug conjugate therapy: internalization and intracellular localization. Harper J; Mao S; Strout P; Kamal A Methods Mol Biol; 2013; 1045():41-9. PubMed ID: 23913140 [TBL] [Abstract][Full Text] [Related]
9. Impact of drug conjugation on pharmacokinetics and tissue distribution of anti-STEAP1 antibody-drug conjugates in rats. Boswell CA; Mundo EE; Zhang C; Bumbaca D; Valle NR; Kozak KR; Fourie A; Chuh J; Koppada N; Saad O; Gill H; Shen BQ; Rubinfeld B; Tibbitts J; Kaur S; Theil FP; Fielder PJ; Khawli LA; Lin K Bioconjug Chem; 2011 Oct; 22(10):1994-2004. PubMed ID: 21913715 [TBL] [Abstract][Full Text] [Related]
10. The Chemical Design and Synthesis of Linkers Used in Antibody Drug Conjugates. Frigerio M; Kyle AF Curr Top Med Chem; 2017; 17(32):3393-3424. PubMed ID: 29357801 [TBL] [Abstract][Full Text] [Related]
11. Improved Lysosomal Trafficking Can Modulate the Potency of Antibody Drug Conjugates. DeVay RM; Delaria K; Zhu G; Holz C; Foletti D; Sutton J; Bolton G; Dushin R; Bee C; Pons J; Rajpal A; Liang H; Shelton D; Liu SH; Strop P Bioconjug Chem; 2017 Apr; 28(4):1102-1114. PubMed ID: 28151644 [TBL] [Abstract][Full Text] [Related]
12. FRET Reagent Reveals the Intracellular Processing of Peptide-Linked Antibody-Drug Conjugates. Lee BC; Chalouni C; Doll S; Nalle SC; Darwish M; Tsai SP; Kozak KR; Del-Rosario G; Yu SF; Erickson H; Vandlen R Bioconjug Chem; 2018 Jul; 29(7):2468-2477. PubMed ID: 29856915 [TBL] [Abstract][Full Text] [Related]
13. Potential mechanisms of target-independent uptake and toxicity of antibody-drug conjugates. Mahalingaiah PK; Ciurlionis R; Durbin KR; Yeager RL; Philip BK; Bawa B; Mantena SR; Enright BP; Liguori MJ; Van Vleet TR Pharmacol Ther; 2019 Aug; 200():110-125. PubMed ID: 31028836 [TBL] [Abstract][Full Text] [Related]
14. Antibody-drug conjugates: an emerging modality for the treatment of cancer. Leal M; Sapra P; Hurvitz SA; Senter P; Wahl A; Schutten M; Shah DK; Haddish-Berhane N; Kabbarah O Ann N Y Acad Sci; 2014 Aug; 1321():41-54. PubMed ID: 25123209 [TBL] [Abstract][Full Text] [Related]
16. Triggered Drug Release from an Antibody-Drug Conjugate Using Fast "Click-to-Release" Chemistry in Mice. Rossin R; van Duijnhoven SM; Ten Hoeve W; Janssen HM; Kleijn LH; Hoeben FJ; Versteegen RM; Robillard MS Bioconjug Chem; 2016 Jul; 27(7):1697-706. PubMed ID: 27306828 [TBL] [Abstract][Full Text] [Related]
17. Homogeneous Antibody-Drug Conjugates via Glycoengineering. Tang F; Shi W; Huang W Methods Mol Biol; 2019; 2033():221-238. PubMed ID: 31332757 [TBL] [Abstract][Full Text] [Related]
18. Chemoenzymatic Conjugation of Toxic Payloads to the Globally Conserved N-Glycan of Native mAbs Provides Homogeneous and Highly Efficacious Antibody-Drug Conjugates. van Geel R; Wijdeven MA; Heesbeen R; Verkade JM; Wasiel AA; van Berkel SS; van Delft FL Bioconjug Chem; 2015 Nov; 26(11):2233-42. PubMed ID: 26061183 [TBL] [Abstract][Full Text] [Related]
19. An enzymatic deconjugation method for the analysis of small molecule active drugs on antibody-drug conjugates. Li Y; Gu C; Gruenhagen J; Yehl P; Chetwyn NP; Medley CD MAbs; 2016; 8(4):698-705. PubMed ID: 26891281 [TBL] [Abstract][Full Text] [Related]
20. Modulating Antibody-Drug Conjugate Payload Metabolism by Conjugation Site and Linker Modification. Su D; Kozak KR; Sadowsky J; Yu SF; Fourie-O'Donohue A; Nelson C; Vandlen R; Ohri R; Liu L; Ng C; He J; Davis H; Lau J; Del Rosario G; Cosino E; Cruz-Chuh JD; Ma Y; Zhang D; Darwish M; Cai W; Chen C; Zhou H; Lu J; Liu Y; Kaur S; Xu K; Pillow TH Bioconjug Chem; 2018 Apr; 29(4):1155-1167. PubMed ID: 29481745 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]